1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM.

    Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(8): 493-498. Nº de citas: 2

    [doi:10.1016/j.eimc.2016.02.029]

  • Masiá M, Padilla S, Moreno S, Barber X, Iribarren JA, Del Romero J, Gómez-Sirvent JL, Rivero M, Vidal F, Campins AA, Gutiérrez F.

    Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.

    Plos One . 12(9): . Nº de citas: 5

    [doi:10.1371/journal.pone.0184329]

  • Geretti AM, Loutfy M, D'Arminio Monforte A, Latysheva I, Pérez Elías MJ, Rymer J, Boffito M.

    Out of focus: tailoring the cascade of care to the needs of women living with HIV.

    HIV MEDICINE . 18 Suppl 2: 3-17. Nº de citas: 7

    [doi:10.1111/hiv.12533]

  • Vivancos MJ, Gómez-Ayerbe C, Moreno S.

    Highlights in HIV, 2016.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 30 Suppl 1: 13-15.

  • Fortún J, Gioia F.

    Invasive candidiasis in the neutropenic patient.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 30 Suppl 1: 22-25. Nº de citas: 4

  • Alpern JD, Lopez-Velez R, Stauffer WM.

    Access to benznidazole for Chagas disease in the United States-Cautious optimism?

    PLOS NEGLECTED TROPICAL DISEASES . 11(9): . Nº de citas: 17

    [doi:10.1371/journal.pntd.0005794]

  • Pérez-Molina JA, López-Polín A, Treviño B, Molina I, Goikoetxea J, Díaz-Menéndez M, Torrús D, Calabuig E, Benito A, López-Vélez R.

    6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain.

    JOURNAL OF TRAVEL MEDICINE . 24(5): . Nº de citas: 28

    [doi:10.1093/jtm/tax035]

  • Moreno Guillen S, Losa García JE, Berenguer Berenguer J, Martínez Sesmero JM, Cenoz Gomis S, Graefenhain R, Lopez Sanchez-Cambronero D, Parrondo Garcia FJ.

    Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.

    FARMACIA HOSPITALARIA . 41(5): 601-610.

    [doi:10.7399/fh.10808]

  • Sanchez Conde M, Vivancos Gallego MJ, Moreno Guillen S.

    Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.

    FARMACIA HOSPITALARIA . 41(5): 630-637.

    [doi:10.7399/fh.10821]

  • Fernández-Ruiz M, Guinea J, Lora-Pablos D, Zaragoza Ó, Puig-Asensio M, Almirante B, Cuenca-Estrella M, Aguado JM, CANDIPOP Project, GEIH-GEMICOMED (SEIMC) and REIPI.

    Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 23(9): . Nº de citas: 18

    [doi:10.1016/j.cmi.2017.01.014]

  • Serrano-Villar S, Vázquez-Castellanos JF, Vallejo A, Latorre A, Sainz T, Ferrando-Martínez S, Rojo D, Martínez-Botas J, Del Romero J, Madrid N, Leal M, Mosele JI, Motilva MJ, Barbas C, Ferrer M, Moya A, Moreno S, Gosalbes MJ, Estrada V.

    The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.

    MUCOSAL IMMUNOLOGY . 10(5): 1279-1293. Nº de citas: 61

    [doi:10.1038/mi.2016.122]

  • Navarro M, Monge-Maíllo B, Flores-Chavez MD, López-Vélez R.

    Hunting hidden parasites: Trypanosoma cruzi.

    Lancet (London, England) . 390(10096): 724-726. Nº de citas: 12

    [doi:10.1016/S0140-6736(17)31536-2]

  • Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Tebe C, Carratalà J, BICAR Study Group.

    Efficacy of ß-Lactam/ß-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-ß-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(8): . Nº de citas: 31

    [doi:10.1128/AAC.00164-17]

  • Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J.

    Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.

    HEPATOLOGY . 66(2): 344-356. Nº de citas: 42

    [doi:10.1002/hep.29071]

  • Poveda E, Hernández-Quero J, Pérez-Elías MJ, Ribas MA, Martínez-Madrid OJ, Flores J, Navarro J, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestaran A, García F, Paredes R.

    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

    HIV MEDICINE . 18(7): 482-489. Nº de citas: 1

    [doi:10.1111/hiv.12479]

  • Henriquez-Camacho C, Villafuerte-Gutierrez P, Pérez-Molina JA, Losa J, Gotuzzo E, Cheyne N.

    Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.

    HIV MEDICINE . 18(6): 419-429. Nº de citas: 20

    [doi:10.1111/hiv.12474]

  • Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJ, Pais MJ, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, San Juan R, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PF, Asseray N, Ansart S, Le Moal G, Zimmerli W, Ariza J, and the Group of Investigators for Streptococcal Prosthetic Joint Infection..

    The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.

    CLINICAL INFECTIOUS DISEASES . 64(12): 1742-1752. Nº de citas: 53

    [doi:10.1093/cid/cix227]

  • Ortiz-Flores A, Gioia F, Montánez-Fernández L, Santacruz E, Martín-Dávila P, Pian-Arias H, Botella-Carretero JI.

    Incidental finding of a primary thyroid tuberculosis.

    Oxford Medical Case Reports . 2017(6): . Nº de citas: 3

    [doi:10.1093/omcr/omx022]